-+ 0.00%
-+ 0.00%
-+ 0.00%

Lonza Group (SWX:LONN) Stock Faces Margin Story Test After Net Profit Reaches 15.7%

Simply Wall St·07/22/2026 23:21:52
语音播报

Lonza Group (SWX:LONN) opened H1 2026 with Total Revenue of CHF 3.4b and Basic EPS of CHF 8.14, alongside Net Income (excluding extra items) of CHF 568m, setting a clear marker for its latest results. The company has seen revenue move from CHF 3.1b and EPS of CHF 5.65 in H1 2025, and CHF 3.1b and EPS of CHF 4.61 in H1 2024, giving investors a concrete view of how the top and bottom lines have tracked over recent reporting periods. With trailing 12 month EPS of CHF 15.47 and net profit margins in the mid-teens, the focus now is on how these earnings and margin trends shape expectations for the next stage of the Lonza Group narrative.

See our full analysis for Lonza Group.

With the headline numbers on the table, the next step is to see how Lonza Group's latest earnings compare with the prevailing market and community narratives, highlighting where the story is confirmed and where it might be challenged.

See what the community is saying about Lonza Group

SWX:LONN Revenue & Expenses Breakdown as at Jul 2026
SWX:LONN Revenue & Expenses Breakdown as at Jul 2026

Lonza Group margins step up to 15.7%

  • Over the last 12 months, Lonza Group reported a net profit margin of 15.7%, compared with 12.2% a year earlier, alongside trailing 12 month net income of CHF 1.1b on CHF 6.9b of revenue.
  • Analysts' consensus view links this margin profile to higher quality earnings, yet it also flags execution risks, as:
    • Expansion projects such as Vacaville and Visp are described as capital intensive, so any delays or underutilisation could weigh on future returns even with a 15.7% margin today.
    • The Capsules and Health Ingredients divestment is expected to free up capital for core operations, while also potentially reducing near term free cash flow compared with this strong trailing margin base.

P/E of 34.7x versus peers at 54.1x

  • Lonza Group is trading on a trailing P/E of 34.7x, below the peer average of 54.1x and slightly below the global life sciences industry at 38x, with a current share price of CHF 536.40.
  • Supporters of the bullish case highlight this relative P/E level, but the numbers also show some tension with that view, because:
    • The DCF fair value is cited at CHF 392.40, which is below the current share price, so investors comparing to cash flow estimates may not see the same value signal as those focusing on P/E multiples.
    • Analyst forecasts for revenue growth of about 10.7% per year and earnings growth of about 16.8% per year underpin a consensus analyst price target of CHF 669.78, which is higher than the current price yet still assumes Lonza trades on a lower P/E in future than today.
On these numbers, bulls are watching whether earnings growth justifies the current multiple or the DCF view wins out, so it can be useful to see how their full argument is laid out in the dedicated bull case for Lonza Group 🐂 Lonza Group Bull Case.

61.8% EPS growth meets higher debt load

  • Over the last 12 months, earnings per share grew 61.8%, with trailing 12 month EPS of CHF 15.47 and H1 2026 net income from ongoing operations of CHF 568 million, while the balance sheet is flagged as carrying a high level of debt.
  • Critics focusing on the bearish angle point to that debt and the DCF fair value as key checks on the story, even alongside strong EPS growth, because:
    • The high debt level is identified as a financial risk, which can matter more as large expansion projects and divestments move through the system, potentially affecting future interest costs and flexibility.
    • The DCF fair value of CHF 392.40 being below the CHF 536.40 share price shows how a cash flow based view can sit uneasily with 61.8% EPS growth, giving bears a concrete valuation figure to reference.
For anyone weighing those debt and valuation concerns against the recent EPS growth, it helps to see how skeptics frame the argument in the detailed bear case on Lonza Group 🐻 Lonza Group Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Lonza Group on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of strong margins, a higher P/E and balance sheet questions leaves you undecided, it is worth moving quickly and reviewing the full risk and reward picture for yourself. You can start with the 5 key rewards and 1 important warning sign.

See What Else Is Out There

Lonza Group combines strong EPS growth with a higher P/E ratio, a DCF value below the current share price, and a balance sheet flagged for high debt.

If the mix of valuation tension and leverage makes you cautious here, it is worth quickly checking stocks in the solid balance sheet and fundamentals stocks screener (420 results) that pair financial strength with clearer pricing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.